Combining antiplatelet and anticoagulant therapy in cardiovascular disease

31Citations
Citations of this article
118Readers
Mendeley users who have this article in their library.

Abstract

Up to 10% of the >3 million Americans with atrial fibrillation will experience an acute coronary syndrome or undergo percutaneous coronary intervention. Therefore, concurrent indications for multiple antithrombotic agents is a common clinical scenario. Although each helps reduce thrombotic risk, their combined use significantly increases the risk of major bleeding events, which can be life threatening. In the past 5 years, a number of randomized clinical trials have explored different combinations of anticoagulation plus antiplatelet agents aimed at minimizing bleeding risk while preserving low thrombotic event rates. In general, shorter courses with fewer antithrombotic agents have been found to be effective, particularly when direct oral anticoagulants are combined with clopidogrel. Combined use of very low-dose rivaroxaban plus aspirin has also demonstrated benefit in atherosclerotic diseases, including coronary and peripheral artery disease. Use of proton pump inhibitor therapy while patients are taking multiple antithrombotic agents has the potential to further reduce upper gastrointestinal bleeding risk in select populations. Applying this evidence to patients with multiple thrombotic conditions will help to avoid costly and life-threatening adverse medication events.

References Powered by Scopus

Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association

6969Citations
N/AReaders
Get full text

2018 ESC/EACTS Guidelines on myocardial revascularization

5593Citations
N/AReaders
Get full text

Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report

4051Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Thrombus Structural Composition in Cardiovascular Disease

135Citations
N/AReaders
Get full text

Effect of P2Y12 Inhibitors on Survival Free of Organ Support among Non-Critically Ill Hospitalized Patients with COVID-19: A Randomized Clinical Trial

100Citations
N/AReaders
Get full text

Antiplatelet Use in Ischemic Stroke

36Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Barnes, G. D. (2020). Combining antiplatelet and anticoagulant therapy in cardiovascular disease. Hematology (United States), 20(1), 642–648. https://doi.org/10.1182/HEMATOLOGY.2020000151

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 24

65%

Researcher 10

27%

Professor / Associate Prof. 3

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 32

63%

Pharmacology, Toxicology and Pharmaceut... 12

24%

Biochemistry, Genetics and Molecular Bi... 4

8%

Nursing and Health Professions 3

6%

Save time finding and organizing research with Mendeley

Sign up for free